← Leaderboards
Xinhua Li
Nano Terra, Inc.
$36,649,898
Attributed
$36,649,898
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $8.6M · FY2017–25$10M$7.5M$5M$2.5M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$36,649,898 · 9
By mechanism
U01$24,018,898 · 2
UG3$6,087,655 · 1
R44$5,528,818 · 2
R43$1,014,527 · 4
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Urine”
- Andrew S Huhn · Johns Hopkins University$16,590,830
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$14,031,836
- Jeanette Coffin · Midwest Research Institute$10,204,323
- Richard Scranton · Lyndra Therapeutics, Inc.$9,277,094
- James N Campbell · Centrexion Therapeutics Corporation$8,662,635
- Jorge Eduardo Chavarro · Harvard School Of Public Health$8,571,098
Research focus
UrineIntoxicationBindingDoseMethamphetaminePharmaceutical PreparationsPlasmaBloodPatient-Focused OutcomesCessation Of LifeFormulationSafetyAcuteNaloxoneTherapeutic AgentsNonhuman PrimateRattusResourcesStandard Of CareSiteKidneySmall MoleculeIn VitroHospitals
Grant awards (17)
Clinical Development of a Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication$3,799,875
U01 · FY2025 · DA · contact PI
A Novel Reversal Agent for Treatment of Overdose from the Combination of Fentanyl and Xylazine$1,536,796
R44 · FY2025 · DA · contact PI
Clinical Development of a Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication$4,092,920
U01 · FY2024 · DA · contact PI
A Therapeutic Agent to Lower the Level of Synthetic Opioids in the Body$3,051,790
UG3 · FY2024 · DA · contact PI
A Novel Reversal Agent for Treatment of Overdose from the Combination of Fentanyl and Xylazine$1,462,687
R44 · FY2024 · DA · contact PI
Clinical Development of a Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication$4,069,920
U01 · FY2023 · DA · contact PI
A Therapeutic Agent to Lower the Level of Synthetic Opioids in the Body$3,035,865
UG3 · FY2023 · DA · contact PI
Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication$4,067,228
U01 · FY2022 · DA · contact PI
Novel Therapeutic Agents to Reverse Opioid Overdose$1,245,607
R44 · FY2022 · DA · contact PI
An oral therapeutic to treat intoxication by prescription and illicit stimulants$319,946
R43 · FY2022 · DA · contact PI
A novel therapeutic approach for treatment of acute intoxication by co-use of opioids and stimulants$319,695
R43 · FY2022 · DA · contact PI
Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication$3,941,786
U01 · FY2021 · DA · contact PI
Novel Therapeutic Agents to Reverse Opioid Overdose$1,283,728
R44 · FY2021 · DA · contact PI
Evaluation of the drug-drug interactions of fentanyl with stimulants in the context of overdose$114,933
U01 · FY2021 · DA · contact PI
Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication$3,932,236
U01 · FY2020 · DA · contact PI
Novel Therapeutic Agents to Reverse Opioid Overdose$224,889
R43 · FY2020 · DA · contact PI
Development of a Nearly Universal Assay Kit for Cell Separations$149,997
R43 · FY2017 · GM · contact PI